Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

5.3K
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rethinking first-line therapy in overactive bladder: is it time for a paradigm shift?

Minerva urology and nephrology·2026
Same author

Enhancing ARPI therapy in HSPC: who, when and why?

Minerva urology and nephrology·2026
Same author

From Genes to Proteins: The Indispensable Role of Proteogenomics in Advancing Clear Cell Renal Cell Carcinoma Research.

International journal of molecular sciences·2026
Same author

Beyond One-Size-Fits-All Active Surveillance for Low-Risk Prostate Cancer: Risk-Adapted Follow-Up, De-Escalation Pathways, and Focal Therapy as Tailored Strategy.

Diagnostics (Basel, Switzerland)·2026
Same author

Multicentre validation of the PRECISE scoring system for prostate MRI during active surveillance.

European radiology·2026
Same author

Nodal maximum standardised uptake value improves PSMA-PET/CT-based nodal staging in intermediate- and high-risk prostate cancer.

BJU international·2026

Related Experiment Video

Updated: Mar 6, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

20.4K

Risk stratification for benign prostatic hyperplasia.

Fabio Zattoni1, Vincenzo Ficarra1,2, Giacomo Novara3

  • 1Academic Medical Centre Hospital Santa Maria della Misericordia, Udine - Italy.

Urologia
|March 19, 2017
PubMed
Summary

Benign prostatic hyperplasia (BPH), a common condition in aging men, causes lower urinary tract symptoms (LUTS) that impact quality of life. Effective management requires focusing on symptom relief and identifying patients at risk for complications beyond just symptom control.

More Related Videos

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.5K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.6K

Related Experiment Videos

Last Updated: Mar 6, 2026

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
05:25

Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing

Published on: August 14, 2019

20.4K
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.5K
Retzius-Sparing Robot-Assisted Radical Prostatectomy
12:10

Retzius-Sparing Robot-Assisted Radical Prostatectomy

Published on: May 19, 2022

9.6K

Area of Science:

  • Urology
  • Geriatric Medicine
  • Public Health

Background:

  • Benign prostatic hyperplasia (BPH) is a prevalent public health concern affecting aging men.
  • BPH is associated with lower urinary tract symptoms (LUTS) that significantly impair quality of life.
  • BPH is a progressive condition, potentially leading to acute urinary retention and the need for surgery.

Purpose of the Study:

  • To shift BPH and LUTS management beyond symptom control alone.
  • To identify patients at risk for unfavorable outcomes associated with BPH.
  • To optimize management strategies and reduce complications through risk stratification.

Main Methods:

  • Review of current BPH and LUTS management approaches.
  • Analysis of risk factors contributing to BPH development.
  • Evaluation of potential risks associated with BPH progression.

Main Results:

  • Current management often focuses solely on symptom control.
  • Risk stratification is crucial for identifying patients prone to adverse outcomes.
  • Tailored treatment based on risk factors can improve symptom reduction and long-term outcomes.

Conclusions:

  • BPH management should incorporate risk stratification for personalized treatment.
  • Identifying risk factors for BPH development and progression is essential for clinicians.
  • Optimized management reduces both bothersome LUTS and long-term BPH complications.